# SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways

_BIOCELL · Wentao Ou, Zijian He, Wencong Zhou et al. · 2026_

Canonical: https://diginpl.com/books/paper-biocell-2026-085785
Last updated: 2026-10-02

## Quick facts

- **Author:** Wentao Ou; Zijian He; Wencong Zhou; Yao Liu; Yaoxing Huang ([Crossref](https://doi.org/10.32604/biocell.2026.085785))
- **Published:** 2026 ([Crossref](https://doi.org/10.32604/biocell.2026.085785))
- **Publisher:** Tech Science Press ([Crossref](https://doi.org/10.32604/biocell.2026.085785))
- **Journal:** BIOCELL ([Crossref](https://doi.org/10.32604/biocell.2026.085785))
- **DOI:** 10.32604/biocell.2026.085785 ([Crossref](https://doi.org/10.32604/biocell.2026.085785))

## Questions

**Who wrote SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways?**  
SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways was written by Wentao Ou, Zijian He, Wencong Zhou, Yao Liu.

**When was SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways first published?**  
SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways was first published in 2026.

## Sources

- [Publisher record (DOI, via Crossref)](https://doi.org/10.32604/biocell.2026.085785)

## Licence and attribution

Open-access publication. Read it free at the publisher: https://doi.org/10.32604/biocell.2026.085785.

## Cite this page

"SEPT9 Is Associated with Gastric Cancer Chemoresistance through HIF-1α and Glycolytic Pathways". DigiNepal. Last updated 2 October 2026. https://diginpl.com/books/paper-biocell-2026-085785. Retrieved 14 November 2026.